deCODE genetics, Inc. (deCODE) is a biopharmaceutical company applying its discoveries in human genetics to develop drugs and diagnostics for common diseases. The Company’s population approach and resources enable the Company to isolate genes and drug ...
Archemix Corp. is a privately-held biopharmaceutical company based in Cambridge, Massachusetts. The company is leading the development of aptamers as a new class of directed therapeutics for the prevention and treatment of chronic and acute diseases. With ...
EpiGenesis is a drug discovery and development company focused on the rapid transformation of genomic data into novel medicines for the treatment of common, but poorly addressed respiratory diseases, including asthma, chronic obstructive pulmonary disease ...
Tolerx is a biopharmaceutical company engaged in the discovery and development of novel therapies for immune-mediated diseases. Tolerx currently has two antibodies in clinical development: otelixizumab and TRX1. TRX1 is a humanized anti-CD4 monoclonal ...
Threshold Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of drugs targeting the microenvironment of solid tumors as treatments for patients living with cancer. The Company has three product candidates, for which ...
Xanthus is a biopharmaceutical company focused on the discovery, development, acquisition and commercialization of small-molecule therapeutics for the treatment of cancer and autoimmune disorders. We believe that our scientific depth and broad clinical ...
Celltech Group plc (LSE: CCH; NYSE: CLL) is one of Europe's largest biotechnology companies, with an innovative development pipeline funded by its profitable, cash-generative pharmaceutical business. Celltech also possesses drug discovery capabilities ...
Vical Incorporated researches and develops biopharmaceutical products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. The Company has three active independent development programs in the ...
About CEPTYR: CEPTYR is the leading company in the field of protein tyrosine phosphatases (PTPs). CEPTYR uses its expertise in PTP science to develop and commercialize pharmaceuticals that improve the lives of cancer patients, and to collaborate with partners ...
Oncology Sciences Corporation (OSCÔ) is a biopharmaceutical company focused on the discovery, maturation and licensing of novel and non-toxic drug technologies for the treatment of cancer and related illnesses. OSC currently holds licenses to two proprietary ...
Anesiva, Inc. (Anesiva) is a biopharmaceutical company focused on the development and commercialization of therapeutic treatments for pain management. Its portfolio of products includes Zingo powder intradermal injection system, which was approved by the ...
Cognetix is a private drug discovery and development company located in Salt Lake City, Utah, focused on commercializing conopeptide-based pharmaceuticals. Conopeptides are bioactive peptides in the venom of marine cone snails. The Company is currently ...
About CEPTYR: CEPTYR is the leading company in the field of protein tyrosine phosphatases (PTPs). CEPTYR uses its expertise in PTP science to develop and commercialize pharmaceuticals that improve the lives of cancer patients, and to collaborate with partners ...
GNI is a global pharmaceutical company dedicated to the discovery, development, and commercialization of new drugs for the treatment of diseases prevalent in Asia.
Inspire Pharmaceuticals, Inc. (Inspire) is a biopharmaceutical company focusing on discovering, developing and commercializing prescription pharmaceutical products in disease areas with commercial potential or unmet medical needs. The Company’s portfolio ...
Phylogica Limited is an Australia-based company that is engaged in the discovery and development of therapeutics directed at proteins and their interactions. Phylogica’s technology is based on its collection of peptides (small parts of proteins), called ...
Celltech Group plc (LSE: CCH; NYSE: CLL) is one of Europe's largest biotechnology companies, with an innovative development pipeline funded by its profitable, cash-generative pharmaceutical business. Celltech also possesses drug discovery capabilities ...
Bionutrics, Inc., OTC BB: BNRX, a biopharmaceutical company, is dedicated to the discovery and development of biologically active compounds derived from natural sources. Technology based on natural, biologically active compounds has applications not only ...
CepTor Corporation is a development-stage biopharmaceutical company engaged in the discovery, development, and commercialization of proprietary, cell-targeted therapeutic products for the treatment of neuromuscular and neurodegenerative diseases with a ...
NewBiotics Inc., of San Diego, is a pharmaceutical developer of breakthrough drugs to treat cancer and infectious disease. The privately held company is applying its Enzyme Catalyzed Therapeutic Activation (ECTA) technology to develop a new generation ...
We are the innovators in the discovery and development of small molecule therapeutics that regulate gene expression through orphan nuclear receptors. X-Ceptor achieves this by integrating multidisciplinary scientific approaches with the dedication, integrity ...
Aderis Pharmaceuticals was founded in 1994 to develop and commercialize a new generation of pharmaceuticals made possible by biotechnology. Our candidates include selectively-acting, small molecule therapeutics to improve and protect the quality of life ...
NicOx is a product-driven biopharmaceutical company dedicated to the development of nitric oxide-donating drugs for unmet medical needs.
Martek Biosciences Corporation (Martek) develops omega-3 docosahexaenoic acid (DHA) products. The Company produces life’sDHA, a vegetarian source of the omega-3 fatty acid DHA, for use in infant formula, prenatal products, foods and beverages, and dietary ...
RiboGene, Inc. is a drug discovery company focused on the identification of novel leads and the development of potential drug candidates for the treatment of infectious diseases. The Company's drug discovery efforts target bacterial, fungal and viral infections ...
Were you able to find the right 275 Providers within biopharmaceutical-discovery ? If you're also a provider of biopharmaceutical-discovery and you're not featured in the business directory yet, you can always Add an entry for free.
Here you can find entries for "biopharmaceutical-discovery" nationwide. In this results list, different companies present their services and products regarding "biopharmaceutical-discovery".
